title: Metabolic reprogramming towards aerobic glycolysis correlates with greater proliferative ability and resistance to metabolic inhibition in CD8 versus CD4 T cells.
abstract: T lymphocytes (T cells) undergo metabolic reprogramming after activation to provide energy and biosynthetic materials for growth, proliferation and differentiation. Distinct T cell subsets, however, adopt metabolic programs specific to support their needs. As CD4 T cells coordinate adaptive immune responses while CD8 T cells become cytotoxic effectors, we compared activation-induced proliferation and metabolic reprogramming of these subsets. Resting CD4 and CD8 T cells were metabolically similar and used a predominantly oxidative metabolism. Following activation CD8 T cells proliferated more rapidly. Stimulation led both CD4 and CD8 T cells to sharply increase glucose metabolism and adopt aerobic glycolysis as a primary metabolic program. Activated CD4 T cells, however, remained more oxidative and had greater maximal respiratory capacity than activated CD8 T cells. CD4 T cells were also associated with greater levels of ROS and increased mitochondrial content, irrespective of the activation context. CD8 cells were better able, however, to oxidize glutamine as an alternative fuel source. The more glycolytic metabolism of activated CD8 T cells correlated with increased capacity for growth and proliferation, along with reduced sensitivity of cell growth to metabolic inhibition. These specific metabolic programs may promote greater growth and proliferation of CD8 T cells and enhance survival in diverse nutrient conditions.
authors.affiliation: Department of Pharmacology and Cancer Biology, Department of Immunology, Sarah W. Stedman Center for Nutrition and Metabolism, Duke University, Durham, NC, United States of America.
authors.forename: Yilin
authors.initials: Y
authors.lastname: Cao
authors.affiliation: Department of Pharmacology and Cancer Biology, Department of Immunology, Sarah W. Stedman Center for Nutrition and Metabolism, Duke University, Durham, NC, United States of America.
authors.forename: Jeffrey C
authors.initials: JC
authors.lastname: Rathmell
authors.affiliation: Department of Pharmacology and Cancer Biology, Department of Immunology, Sarah W. Stedman Center for Nutrition and Metabolism, Duke University, Durham, NC, United States of America.
authors.forename: Andrew N
authors.initials: AN
authors.lastname: Macintyre
mesh_terms: D056704:Adaptive Immunity / Q000276:immunology*; D000332:Aerobiosis / Q000276:immunology; D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000378:metabolism*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology / Q000378:metabolism*; D019070:Cell Lineage; D005947:Glucose / Q000378:metabolism*; D006019:Glycolysis / Q000276:immunology; D008213:Lymphocyte Activation / Q000276:immunology; D053858:Metabolic Networks and Pathways / Q000276:immunology; D051379:Mice; D008928:Mitochondria / Q000276:immunology / Q000378:metabolism; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology / Q000378:metabolism
chemical_list: D005947:Glucose
references.citation: Immunopharmacology. 1998 Jun;39(3):201-13
references.pmid: 9754906
references.citation: Am J Physiol Cell Physiol. 2007 Jan;292(1):C125-36
references.pmid: 16971499
references.citation: Immunity. 2012 Jan 27;36(1):68-78
references.pmid: 22206904
references.citation: Semin Immunol. 2012 Dec;24(6):429-35
references.pmid: 23352227
references.citation: Curr Opin Immunol. 2000 Aug;12(4):448-55
references.pmid: 10899032
references.citation: Methods Enzymol. 2008;442:439-57
references.pmid: 18662583
references.citation: Annu Rev Immunol. 2013;31:259-83
references.pmid: 23298210
references.citation: Biochim Biophys Acta. 1988 Jun 8;970(1):1-6
references.pmid: 3370225
references.citation: Immunol Rev. 2009 May;229(1):173-91
references.pmid: 19426222
references.citation: Annu Rev Cell Dev Biol. 2011;27:441-64
references.pmid: 21985671
references.citation: Nat Rev Immunol. 2013 Apr;13(4):227-42
references.pmid: 23470321
references.citation: Nature. 2008 Mar 13;452(7184):230-3
references.pmid: 18337823
references.citation: J Neuroimmunol. 1994 Jul;52(2):165-73
references.pmid: 8034756
references.citation: Nat Immunol. 2013 May;14(5):500-8
references.pmid: 23525088
references.citation: Proc Natl Acad Sci U S A. 1987 Apr;84(7):2002-6
references.pmid: 3031660
references.citation: J Immunol. 2002 Feb 15;168(4):1528-32
references.pmid: 11823476
references.citation: Mol Cell. 2000 Sep;6(3):683-92
references.pmid: 11030347
references.citation: PLoS One. 2011;6(5):e20107
references.pmid: 21611151
references.citation: J Immunol. 2003 Oct 15;171(8):3928-35
references.pmid: 14530309
references.citation: J Exp Med. 2011 Jul 4;208(7):1367-76
references.pmid: 21708926
references.citation: J Immunol. 2008 Apr 1;180(7):4476-86
references.pmid: 18354169
references.citation: Cytometry A. 2011 Feb;79(2):95-101
references.pmid: 21265003
references.citation: J Immunol. 1994 Mar 15;152(6):2660-8
references.pmid: 8144874
references.citation: Biochim Biophys Acta. 1990 Sep 10;1087(1):1-6
references.pmid: 2169315
references.citation: Clin Cancer Res. 2012 Oct 15;18(20):5554-61
references.pmid: 23071357
references.citation: Immunity. 2002 Jun;16(6):769-77
references.pmid: 12121659
references.citation: Nat Rev Immunol. 2009 Jul;9(7):480-90
references.pmid: 19543225
references.citation: Int J Biochem. 1991;23(9):823-6
references.pmid: 1773887
references.citation: Int J Cell Biol. 2013;2013:242513
references.pmid: 23476652
references.citation: Science. 2005 Nov 18;310(5751):1159-63
references.pmid: 16293754
references.citation: J Immunol. 2011 Mar 15;186(6):3299-303
references.pmid: 21317389
references.citation: Immunity. 2014 May 15;40(5):692-705
references.pmid: 24792914
references.citation: Cell. 2013 Jun 6;153(6):1239-51
references.pmid: 23746840
references.citation: Proc Natl Acad Sci U S A. 2013 Aug 27;110(35):14336-41
references.pmid: 23940348
references.citation: J Immunol. 2005 Apr 15;174(8):4670-7
references.pmid: 15814691
references.citation: Cell Metab. 2014 Jul 1;20(1):61-72
references.pmid: 24930970
references.citation: Immunology. 2000 Mar;99(3):394-401
references.pmid: 10712669
references.citation: J Exp Med. 1997 Jul 7;186(1):47-55
references.pmid: 9206996
references.citation: Nat Immunol. 2013 Oct;14(10):1064-72
references.pmid: 23955661
references.citation: Am J Physiol Lung Cell Mol Physiol. 2012 Feb 1;302(3):L300-7
references.pmid: 22080752
references.citation: Biochim Biophys Acta. 1989 Mar 6;1010(3):342-5
references.pmid: 2920182
references.citation: Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18348-53
references.pmid: 22042850
references.citation: Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2788-93
references.pmid: 16477002
references.citation: Sci Transl Med. 2011 Jan 26;3(67):67ra8
references.pmid: 21270339
references.citation: Immunity. 2011 Dec 23;35(6):871-82
references.pmid: 22195744
references.citation: J Immunol. 2002 Nov 1;169(9):4882-8
references.pmid: 12391199
references.citation: Cancer Metab. 2013 Jan 23;1(1):5
references.pmid: 24280044